ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is 3.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $895,000 | -57.5% | 248,600 | -61.6% | 0.06% | -48.2% |
| Q1 2017 | $2,107,000 | +8.5% | 648,200 | -18.2% | 0.11% | +0.9% |
| Q4 2016 | $1,942,000 | -35.7% | 792,617 | -9.8% | 0.11% | 0.0% |
| Q3 2016 | $3,022,000 | -26.2% | 878,531 | -25.3% | 0.11% | -47.2% |
| Q2 2016 | $4,093,000 | -17.2% | 1,176,031 | -1.8% | 0.21% | -13.4% |
| Q1 2016 | $4,945,000 | +11.1% | 1,197,338 | +19.7% | 0.25% | +0.8% |
| Q4 2015 | $4,450,000 | +0.8% | 1,000,000 | +37.9% | 0.24% | +34.6% |
| Q3 2015 | $4,415,000 | – | 725,007 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |